Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc. Robbins LLP is Investigating Allegations that Allarity Therapeutics, Inc. (ALLR) Misled Investors Regarding Dovitinib NDA’s Regulatory Prospects